<DOC>
	<DOCNO>NCT00399451</DOCNO>
	<brief_summary>The aim prospective study evaluate result polidocanol sclerotherapy pharynx OSAS &amp; SS , reduce pharyngeal compliance .</brief_summary>
	<brief_title>Polidocanol Sclerotherapy Pharynges Obstructive Sleep Apnea ( OSA ) Snoring Subjects ( SS )</brief_title>
	<detailed_description>Polidocanol submucous sclerosis part pharynges 1 % polidocanol injection.The injection retropharyngeal submucosa lateral pharyngeal band lateral pharyngeal submucosa front submucosa soft palate.The injection multi-point , point injection 0.3~0.5ml ; total quantity/each time 5ml.Every patient treat 1~2 time .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Snoring</mesh_term>
	<mesh_term>Polidocanol</mesh_term>
	<criteria>OSAS &amp; SS palatopharyngeal collapse . obstructive sleep apnea syndrome ( osas ) &amp; snore subject ( s ) , anatomic narrow result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Sleep Apnea , Obstructive</keyword>
	<keyword>apnea-hypopnea index ( AHI )</keyword>
	<keyword>polidocanol</keyword>
	<keyword>sclerotherapy</keyword>
	<keyword>pharynx</keyword>
</DOC>